Reference
Iannone M, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa. Clinics in Dermatology 39: 701-702, No. 4, Jul 2021. Available from: URL: http://doi.org/10.1016/j.clindermatol.2021.05.026
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1896, 19 (2022). https://doi.org/10.1007/s40278-022-10810-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-10810-9